The clinical pharmacology of methotrexate
- 31 March 1983
- journal article
- review article
- Published by Elsevier in Cancer Treatment Reviews
- Vol. 10 (1) , 53-75
- https://doi.org/10.1016/s0305-7372(83)80032-2
Abstract
No abstract availableThis publication has 71 references indexed in Scilit:
- A randomized prospective comparison of intermittent methotrexate, methotrexate with leucovorin, and a methotrexate combination in head and neck cancerCancer, 1981
- Renal clearance of methotrexate in man during high-dose oral and intravenous infusion therapyCancer Chemotherapy and Pharmacology, 1981
- Limited effectiveness of in vitro high-dose methotrexate and leucovorin to overcome resistance in L1210 leukemia cells with elevations of dihydrofolate reductasePublished by Elsevier ,1980
- Effect of oral prophylactic broad spectrum nonabsorbable antibiotics on the gastrointestinal absorption of nutrients and methotrexate in small cell bronchogenic carcinoma patientsCancer, 1976
- The Clinical Pharmacology of Antineoplastic AgentsNew England Journal of Medicine, 1975
- Threshold Methotrexate Concentration for In Vivo Inhibition of DNA Synthesis in Normal and Tumorous Target TissuesJournal of Clinical Investigation, 1973
- Enzymatic Cleavage of Methotrexate provides a Method for Prevention of Drug ToxicityNature, 1972
- Site of action of methotrexate in psoriasisArchives of Dermatology, 1969
- Continuous infusion of methotrexate in children with acute leukemiaCancer, 1967
- Long-Term Remissions in Childhood Acute LeukemiaClinical Pediatrics, 1966